FDA recall, , Low risk
Community Blood Center Of Greater Kansas City Apheresis Red Blood Cells
Apheresis Red Blood Cells, Leukocytes Reduced were distributed after a donor's health history screening was not adequately performed.
Recall ended Feb 13, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
Community Blood Center Of Greater Kansas City recalled Apheresis Red Blood Cells, Leukocytes Reduced products because they were collected from a donor whose health history screening was not adequately performed. The recall began on March 13, 2025, and was added to the FDA's Enforcement Report on February 13, 2026. The affected products were distributed in Kansas.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- Community Blood Center Of Greater Kansas City
- Hazard
- Blood donor screening
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 98286
- Recall number
- B-0020-2026
- Quantity recalled
- 2 units
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
